Arvest Trust’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,731
Closed -$297K 177
2023
Q4
$297K Hold
3,731
0.02% 150
2023
Q3
$265K Hold
3,731
0.02% 138
2023
Q2
$285K Buy
3,731
+68
+2% +$5.26K 0.02% 143
2023
Q1
$275K Buy
3,663
+1
+0% +$74 0.02% 131
2022
Q4
$289K Sell
3,662
-593
-14% -$44.5K 0.02% 142
2022
Q3
$299K Buy
4,255
+352
+9% +$27.6K 0.02% 140
2022
Q2
$313K Sell
3,903
-752
-16% -$58.8K 0.02% 124
2022
Q1
$353K Sell
4,655
-637
-12% -$50.5K 0.02% 130
2021
Q4
$452K Buy
+5,292
New +$413K 0.02% 122
2014
Q2
$15.7M Sell
230,151
-57
-0% -$3.82K 1.45% 17
2014
Q1
$15.5M Sell
230,208
-1,800
-0.8% -$113K 1.5% 16
2013
Q4
$15.1M Sell
232,008
-5,703
-2% -$365K 1.5% 20
2013
Q3
$14.1M Buy
237,711
+194
+0.1% +$11.5K 1.54% 24
2013
Q2
$13.6M Buy
+237,517
New +$14.1M 1.56% 25

Other funds holding CL

Arvest Trust's CL Position: Q1 2024 in Review

Arvest Trust sold out of Colgate-Palmolive (CL) in Q1 2024, closing a stake of 3,731 shares — an estimated $297K sold.

Arvest Trust first reported a position in CL in Q2 2013 and held it in 14 quarters. The position peaked at $15.7M in Q2 2014. 1,766 funds tracked by Wall St. Rank hold CL as of Q1 2024.

  • Arvest Trust reported no remaining Colgate-Palmolive position as of Q1 2024 after selling out during the quarter.
  • Arvest Trust sold 3,731 Colgate-Palmolive shares in Q1 2024, an estimated $297K.
  • Arvest Trust first reported a position in Colgate-Palmolive in Q2 2013 and held it in 14 quarters.
  • Arvest Trust's Colgate-Palmolive position peaked at $15.7M in Q2 2014.
  • 1,766 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2024.

Based on Arvest Trust's 13F filing for Q1 2024, filed 15 May 2024.